Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Scientists at Erasmus University, Department of Virology target vaccines
September 17th, 2008
Scientists discuss in 'Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques' new findings in vaccines. According to a study from Rotterdam, Netherlands, "Human metapneumovirus (HMPV) is an important cause of acute respiratory tract disease for which the development of vaccine candidates is warranted. We have previously described the generation of an iscom matrix-adjuvanted HMPV fusion protein subunit vaccine (Fsol) and a live-attenuated vaccine (HMPVM11)." "Here, we evaluate the immunogenicity and efficacy of these vaccines in cynomolgus macaques. Immunization with Fsol induced HMPV F-specific antibody responses, virus...
Source: Vaccine Weekly (2008-09-17)
|
